Medicare Enrolled

Dr. Steven Ryder, MD

Retina Specialist (Ophthalmology) Physician · Charlotte, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
135 S SHARON AMITY RD STE 100, Charlotte, NC 28211
7043650555
In practice since 2011 (15 years)
NPI: 1366732851 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Ryder from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ryder? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Ryder

Dr. Steven Ryder is a retina specialist physician in Charlotte, NC, with 15 years of NPI registration. Based on federal Medicare data, Dr. Ryder performed 51,981 Medicare services across 3,583 unique beneficiaries.

Between the years covered by Open Payments, Dr. Ryder received a total of $5,727 from 28 pharmaceutical and/or device companies across 135 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Ryder is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 15 years in practice ▲ Top 14% volume in NC $5,727 industry payments

Medicare Practice Summary

Medicare Utilization ↗
51,981
Medicare services
Top 14% in NC for retina specialist (ophthalmology) physician
3,583
Unique beneficiaries
$52
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~3,465 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
40,800 $29 $54
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
2,528 $30 $109
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
2,199 $88 $240
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,632 $90 $650
Injection, ranibizumab, 0.1 mg 941 $181 $597
Aflibercept eye injection (Eylea) 846 $692 $1,465
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
675 $120 $189
Dexamethasone intravitreal implant injection
An injection of a dexamethasone implant placed inside the eye. This procedure delivers medication directly into the vitreous cavity of the eye.
504 $159 $286
Bevacizumab injection, 10 mg
Administration of a 10 mg dose of bevacizumab medication via injection.
478 $56 $150
Principal care management for high-risk disease, first 30 minutes
This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional.
465 $47 $124
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
407 $83 $207
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
145 $11 $120
Additional 30 minutes of principal care management
This service covers each additional 30 minutes of clinical staff time directed by a healthcare professional for managing a single high-risk disease, billed per calendar month.
89 $36 $98
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
76 $26 $149
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
62 $103 $289
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
40 $94 $248
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
26 $2,177 $5,965
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
21 $34 $240
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
18 $847 $3,200
Vitreous removal between lens and retina
This procedure involves the removal of the vitreous fluid located between the lens and the retina of the eye.
16 $597 $3,200
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
13 $62 $165
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$5,727
Total received (2018-2024)
Avg $818/year across 7 years
Top 35% in NC for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
28
Companies
135
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$3,544 (61.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,541 (26.9%)
Financial / Ownership
Ownership or investment interests, royalties, and licensing fees
$641 (11.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$858
2023
$1,106
2022
$1,573
2021
$959
2020
$260
2019
$602
2018
$369

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$206
Alimera Sciences, Inc.
$204
Notal Vision, Inc.
$107
Regeneron Healthcare Solutions, Inc.
$88
Apellis Pharmaceuticals, Inc.
$81
Biogen, Inc.
$57
Tarsus Pharmaceuticals, Inc.
$40
Amgen Inc.
$31
Astellas Pharma US Inc
$23
Genentech USA, Inc.
$22
Top 3 companies account for 60.3% of 2024 payments
All-time payments by company (2018-2024) ›
Notal Vision, Inc.
$1,465
Genentech USA, Inc.
$726
US Retina LLC
$641
Regeneron Healthcare Solutions, Inc.
$348
Alimera Sciences, Inc.
$322
ABBVIE INC.
$300
Apellis Pharmaceuticals, Inc.
$240
Allergan, Inc.
$192
NotalVision
$184
Allergan Inc.
$144
Biogen, Inc.
$124
Coherus Biosciences Inc.
$124
Aerie Pharmaceuticals, Inc.
$122
Spark Therapeutics, Inc.
$97
Novartis Pharmaceuticals Corporation
$88
Horizon Therapeutics plc
$83
EyePoint Pharmaceuticals US, Inc.
$82
Bausch & Lomb, a division of Bausch Health US, LLC
$80
Carl Zeiss Meditec, Inc.
$70
AbbVie Inc.
$55
Bausch & Lomb Americas Inc.
$55
Astellas Pharma US Inc
$40
Tarsus Pharmaceuticals, Inc.
$40
Amgen Inc.
$31
Sun Pharmaceutical Industries Inc.
$21
Eyevance Pharmaceuticals LLC
$21
Shire North American Group Inc
$17
Mallinckrodt LLC
$17
Top 3 companies account for 49.4% of all-time payments
Associated products mentioned in payments ›
ACTHAR · BEOVU · BESIVANCE · BYOOVIZ · CEQUA · Cimerli · DUREZOL · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Flarex · Foresee Home · ForeseeHome · ILUVIEN · Iluvien · Izervay · LUXTURNA · Lucentis · OZURDEX · PROLENSA · RESTASIS MULTIDOSE · Rhopressa · SUSVIMO · Syfovre · TEPEZZA · VABYSMO · VISUDYNE · VYZULTA · Vabysmo · XDEMVY · XIIDRA · XIPERE · YUTIQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (62%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a retina specialist physician in Charlotte?
Compare retina specialist physicians in the Charlotte area by procedure volume, costs, and industry payment transparency.
Browse retina specialist physicians nearby

Geographic Context

Retina specialist physicians within 10 mi
9
Per 100K population
0.8
County median income
$83,765
Nearest hospital
ATRIUM HEALTH PINEVILLE
4.2 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Ryder is a mixed practice specialist, with above-average Medicare volume (top 14% in NC), with low-engagement industry engagement, with 15 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Ryder experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Ryder performed 40,800 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ryder receive payments from pharmaceutical companies?
Yes. Dr. Ryder received a total of $5,727 from 28 companies across 135 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ryder's costs compare to other retina specialist physicians in Charlotte?
Dr. Ryder's average Medicare payment per service is $52. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ryder) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →